日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Coronary anatomy detects, ischemia predicts: Real-world insights from the Nancy ischemia registry

冠状动脉解剖结构可检测缺血,预测缺血:来自南希缺血登记研究的真实世界见解

Chati, Zukaï; Benzaghou, Nacima; Balaj, Clémence; Tissier, Samuel

Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial

在既往未接受过治疗的转移性胰腺导管腺癌患者中,NALIRIFOX方案与白蛋白结合型紫杉醇+吉西他滨方案相比,在健康相关生活质量和体能状态方面的表现:NAPOLI 3试验结果

Melisi, D; Macarulla, T; De La Fouchardière, C; Pazo Cid, R A; Chandana, S R; Kiss, I; Lee, W J; Goetze, T O; Van Cutsem, E; Paulson, A S; Bekaii-Saab, T; Pant, S; Hubner, R A; Maxwell, F; Zhang, L; Benzaghou, F; O'Reilly, E M; Wainberg, Z A

A plain language summary of NALIRIFOX compared with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer (NAPOLI 3)

NAPOLI 3 研究比较了 NALIRIFOX 与 nab-紫杉醇和吉西他滨治疗转移性胰腺癌患者的疗效,并总结了以下简明语言结果:

Wainberg, Zev A; Melisi, Davide; Macarulla, Teresa; Pazo Cid, Roberto; Chandana, Sreenivasa R; De La Fouchardière, Christelle; Dean, Andrew; Kiss, Igor; Jin Leei, Woo; Goetze, Thorsten O; Van Cutsem, Eric; Paulson, A Scott; Bekaii-Saab, Tanios; Pant, Shubham; Hubner, Richard A; Xiao, Zhimin; Chen, Huanyu; Benzaghou, Fawzi; O'Reilly, Eileen M

RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

RESILIENT 第二部分:一项随机、开放标签的 III 期研究,比较脂质体伊立替康与拓扑替康治疗复发性小细胞肺癌成人患者的疗效

Spigel, David R; Dowlati, Afshin; Chen, Yuanbin; Navarro, Alejandro; Yang, James Chih-Hsin; Stojanovic, Goran; Jove, Maria; Rich, Patricia; Andric, Zoran G; Wu, Yi-Long; Rudin, Charles M; Chen, Huanyu; Zhang, Li; Yeung, Stanley; Benzaghou, Fawzi; Paz-Ares, Luis; Bunn, Paul A

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

在初治转移性胰腺导管腺癌患者中,NALIRIFOX 与白蛋白结合型紫杉醇联合吉西他滨的疗效比较(NAPOLI 3):一项随机、开放标签的 3 期试验

Wainberg, Zev A; Melisi, Davide; Macarulla, Teresa; Pazo Cid, Roberto; Chandana, Sreenivasa R; De La Fouchardière, Christelle; Dean, Andrew; Kiss, Igor; Lee, Woo Jin; Goetze, Thorsten O; Van Cutsem, Eric; Paulson, A Scott; Bekaii-Saab, Tanios; Pant, Shubham; Hubner, Richard A; Xiao, Zhimin; Chen, Huanyu; Benzaghou, Fawzi; O'Reilly, Eileen M

Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study

按地区分析接受卡博替尼或依维莫司治疗的晚期肾细胞癌患者的预后:METEOR 研究的亚组分析

Schmidinger, Manuela; Motzer, Robert J; Rolland, Frederic; Staehler, Michael; Rink, Michael; Retz, Margitta; Csoszi, Tibor; McCaffrey, John A; De Giorgi, Ugo; Caserta, Claudia; Duran, Ignacio; Benzaghou, Fawzi; Clary, Douglas O; Albiges, Laurence; Choueiri, Toni K; Tannir, Nizar M

Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches

通过务实的方法优化欧盟儿科医学发展

Rei Bolislis, Winona; Bejeuhr, Gesine; Benzaghou, Fawzi; Corriol-Rohou, Solange; Herrero-Martinez, Esteban; Hildebrand, Heidrun; Hill-Venning, Claire; Hoogland, Hans; Johnson, Craig; Joos, Angelika; Vart, Richard; Le Visage, Geneviève; Kühler, Thomas C

Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure

TOOKAD® Soluble 靶向血管光动力疗法治疗局限性前列腺癌:流程标准化

Azzouzi, Abdel-Rahmene; Lebdai, Souhil; Benzaghou, Fawzi; Stief, Christian